174 related articles for article (PubMed ID: 24080573)
1. Integrating advances in insulin into clinical practice: Advances In insulin formulations.
King A
J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S9-17. PubMed ID: 24080573
[TBL] [Abstract][Full Text] [Related]
2. Integrating advances in insulin into clinical practice: Overview of current insulin formulations.
Rhinehart AS
J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S4-8. PubMed ID: 24080572
[TBL] [Abstract][Full Text] [Related]
3. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?
Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K
Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155
[TBL] [Abstract][Full Text] [Related]
4. Novel and Emerging Insulin Preparations for Type 2 Diabetes.
Cheung KK; Alexander P
Can J Diabetes; 2015 Dec; 39 Suppl 5():S160-6. PubMed ID: 26653255
[No Abstract] [Full Text] [Related]
5. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
[TBL] [Abstract][Full Text] [Related]
6. Concentrated insulins in current clinical practice.
Schloot NC; Hood RC; Corrigan SM; Panek RL; Heise T
Diabetes Res Clin Pract; 2019 Feb; 148():93-101. PubMed ID: 30583034
[TBL] [Abstract][Full Text] [Related]
7. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
8. Insulin: Making Sense of Current Options.
Segal AR; Vootla T; Beaser RS
Endocrinol Metab Clin North Am; 2016 Dec; 45(4):845-874. PubMed ID: 27823608
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy.
Hsia E; Seggelke SA; Gibbs J; Rasouli N; Draznin B
Nutr Clin Pract; 2011 Dec; 26(6):714-7. PubMed ID: 22205560
[TBL] [Abstract][Full Text] [Related]
10. Why Do Some Concentrated Insulins Maintain Their Pharmacokinetics/Pharmacodynamics Profile?
Hood RC
Diabetes Technol Ther; 2017 Apr; 19(4):203-205. PubMed ID: 28418731
[No Abstract] [Full Text] [Related]
11. Incretin-based therapies for type 2 diabetes mellitus: current status and future prospects.
Drab SR
Pharmacotherapy; 2010 Jun; 30(6):609-24. PubMed ID: 20500049
[TBL] [Abstract][Full Text] [Related]
12. [Oral treatment of type 2 diabetes mellitus].
Palitzsch KD
Dtsch Med Wochenschr; 2012 Sep; 137(38):1859-68, quiz 1869-72. PubMed ID: 22971973
[No Abstract] [Full Text] [Related]
13. What is the role of concentrated insulin in diabetes management?
Mospan CM
JAAPA; 2016 Jun; 29(6):16-8. PubMed ID: 27228041
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus and the risk of cancer.
Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
[TBL] [Abstract][Full Text] [Related]
15. Insulin preparations with prolonged effect.
Owens DR
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S5-14. PubMed ID: 21668337
[TBL] [Abstract][Full Text] [Related]
16. Targeting the incretin system in type 2 diabetes mellitus.
Potenza M; Rayfield EJ
Mt Sinai J Med; 2009 Jun; 76(3):244-56. PubMed ID: 19421968
[TBL] [Abstract][Full Text] [Related]
17. Management of diabetic cats with long-acting insulin.
Roomp K; Rand JS
Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):251-66. PubMed ID: 23522171
[TBL] [Abstract][Full Text] [Related]
18. The new insulins.
Crotty S; Reynolds SL
Pediatr Emerg Care; 2007 Dec; 23(12):903-5; quiz 906-7. PubMed ID: 18091602
[TBL] [Abstract][Full Text] [Related]
19. Insulin glulisine: an evaluation of its pharmacodynamic properties and clinical application.
Helms KL; Kelley KW
Ann Pharmacother; 2009 Apr; 43(4):658-68. PubMed ID: 19336657
[TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of type 2 diabetes mellitus.
Israili ZH
Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
